Skip to content
Stop using now Drug recall · FDA · Published July 18, 2024

MAIN PRODUCTS INC Umary Acido Hialuronico Caplets Recall: Unapproved Ingredients Found

FDA recalls MAIN PRODUCTS INC's Umary Acido Hialuronico 850mg caplets due to undeclared Diclofenac and Omeprazole. Stop using immediately as these ingredients are unapproved and potentially harmful.

🇺🇸 FDA recall #D-0626-2024DrugMAIN PRODUCTS INC ›
Take action

Contact the company

Recalling firmMAIN PRODUCTS INC1551 Glenwood Springs Ave · Chula Vista, CA 91913-3910
✎ GovInfoNow plain-language explainer

MAIN PRODUCTS INC is recalling 850mg Umary Acido Hialuronico caplets because they were sold without FDA approval and contain undeclared ingredients that could be harmful. This recall affects consumers who bought these supplements before the expiry date. Read more at govinfonow.com/recall/32585-main-products-inc-umary-acido-hialuronico-caplets-recall-unapproved-ingredients.

Source Summary by GovInfoNow · govinfonow.com/recall/32585-main-products-inc-umary-acido-hialuronico-caplets-recall-unapproved-ingredients · Updated August 17, 2026 · FDA enforcement record: FDA #D-0626-2024

Cite this page

“MAIN PRODUCTS INC Umary Acido Hialuronico Caplets Recall: Unapproved Ingredients Found.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32585-main-products-inc-umary-acido-hialuronico-caplets-recall-unapproved-ingredients. Based on FDA recall #D-0626-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0626-2024%22&limit=1).

The FDA announced on July 18, 2024, that MAIN PRODUCTS INC is recalling Umary Acido Hialuronico supplements due to undeclared Diclofenac and Omeprazole. The agency states the product was marketed without an approved New Drug Application or Abbreviated New Drug Application.

How to tell if you have it

  • Brand: MAIN PRODUCTS INC
  • Product: Umary Acido Hialuronico, Suplemento Alimenticio, 850 mg caplets
  • Packaging: 30-count bottles
  • Lots: All lots within expiry

The hazard

FDA analysis found the product to be tainted with undeclared Diclofenac and Omeprazole. The agency classified this as a Class I recall, indicating a high risk of adverse health consequences.

Context

GovInfoNow's records show other recent recalls of similar products include Buy-Herbal Kian Pee Wan Capsules Recall (2026-03-21) and StuffbyNainax MR 7 SUPER 700000 Capsules (2025-12-15). Xyvona (Levorphanol) 2mg Tablet Recall occurred on 2026-05-22.

How to tell if you have this one

Check for 850mg Umary Acido Hialuronico caplets in 30-count bottles. The product was sold with all lots within the expiry date.

  • Brand
    MAIN PRODUCTS INC
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Stop Using Now

    Immediately stop using the recalled Umary Acido Hialuronico caplets as they contain undeclared ingredients that could be harmful.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide within the U.S” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 27 days after the firm started it.

1. Firm started the recall: Jul 18, 202412. FDA classified it Class I: Aug 5, 202423. Published in FDA’s Enforcement Report: Aug 14, 202432024
  1. Firm started the recall
  2. FDA classified it Class I
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

What should I do if I have this product?

Stop using it immediately and contact the manufacturer for further instructions.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0626-2024 (July 18, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0626-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA